Term
|
Definition
| "•Tablets: 10 mg (white, ZENECA/ACCOLATE 20) 20 mg (white, ZENECA/ACCOLATE 20)" |
|
|
Term
|
Definition
| "•Tablets (brown): 5 mg (#PD 527), 10 mg (#PD 530), 20 mg (#PD 532), and 40 mg (#PD 535)" |
|
|
Term
|
Definition
| "•Capsules: 10 mg (pink), 20 mg (maroon), and 40 mg (yellow)" |
|
|
Term
|
Definition
| "•Tablets, delayed-release: 20 mg (light yellow, enteric-coated)" |
|
|
Term
|
Definition
| "•Tablets: 5 mg (yellow, #RSN/5), 30 mg (white, #RSN/30), and 35 mg (orange, #RSN/35)" |
|
|
Term
|
Definition
| "•Tablets: 15 mg (white), 30 mg (white), and 45 mg (white)" |
|
|
Term
|
Definition
| "•Tablets, sustained release: 30 mg (pink) 60 mg (salmon) 90 mg (dark red)" |
|
|
Term
|
Definition
| "•Tablets* (Each tablet contains equal amounts of dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate): 5 mg (blue, scored, #AD/5), 7.5 mg (blue, scored, #AD/7.5), 10 mg (blue, scored, #AD/10), 12.5 mg (orange, scored, #AD/12.5), 15 mg (orange, scored, #AD/15), 20 mg (orange, scored, #AD/20), and 30 mg (orange, scored, #AD/30) •Capsules, extended-release (Each Adderall XR capsule contains equal amounts of dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate): 10 mg (blue, #SHIRE 381 10mg), 20 mg (orange, #SHIRE 381 20 mg), and 30 mg (neutral/orange, #SHIRE 381 30 mg)" |
|
|
Term
|
Definition
| •Advair Diskus 100/50: Each blister contains 100 mcg of microfine fluticasone propionate and 72.5 mcg of microfine salmeterol xinafoate (equivalent to 50 mcg salmeterol). Each Diskus contains 60 blisters. •Advair Diskus 250/50: Each blister contains 250 mcg of microfine fluticasone propionate and 72.5 mcg of microfine salmeterol xinafoate (equivalent to 50 mcg salmeterol). Each Diskus contains 60 blisters. •Advair Diskus 500/50: Each blister contains 500 mcg of microfine fluticasone propionate and 72.5 mcg of microfine salmeterol xinafoate (equivalent to 50 mcg salmeterol). Each Diskus contains 60 blisters. |
|
|
Term
|
Definition
| "•Tablets: 25 mg, 50 mg, and 100 mg" |
|
|
Term
|
Definition
| "•Tablets, 21 day pill pak: Levonorgestrel 0.10 mg, ethinyl estradiol 20 mcg (pink, #W/912) •Tablets, 28 day Pilpak: Levonorgestrel 0.10 mg, ethinyl estradiol 20 mcg (pink, #W/912) plus 7 inert tablets (light green, #W/650)" |
|
|
Term
|
Definition
| "•Tablets: 30 mg (tan), 60 mg (tan), and 180 mg (tan)" |
|
|
Term
|
Definition
| •Tablets: Each tablet (two-layered with white and tan halves) contains 60 mg fexofenadine HCl and 120 mg pseudoephedrine HCl in an extended release tablet matrix. |
|
|
Term
|
Definition
| •Ophthalmic Solution: 0.15% brimonidine tartrate with Purite® 0.005% as a preservative. |
|
|
Term
|
Definition
| "•Capsules: 1.25 mg (yellow), 2.5 mg (orange), 5 mg (red), 10 mg (blue)" |
|
|
Term
|
Definition
| •Tablets: 1 mg (pink) 2 mg (green) 4 mg (blue) |
|
|
Term
|
Definition
| "•Tablets: 5 mg (pink, #AMB 5/5401) and 10 mg (white, #AMB 10/5421)" |
|
|
Term
|
Definition
| "•Tablets, chewable: 125 mg, 200 mg, 250 mg, 400 mg •Tablets: 500 mg and 875 mg •Capsules: 250 mg and 500 mg •Powder for Oral Suspension: 50 mg/ml following reconstitution 125 mg, 200 mg, 250 mg, and 400 mg/5 mL following reconstitution 3 grams following reconstitution (single dose bottle)" |
|
|
Term
|
Definition
| •Anaprox Tablets: 275 mg naproxen sodium (250 mg naproxen) •Anaprox DS Tablets: 550 mg (500 mg naproxen) |
|
|
Term
|
Definition
| "•Tablets: 12.5 mg (blue/white wafer, #Antivert/210), 25 mg (yellow/white wafer, #Antivert/211), 50 mg (blue/yellow wafer, scored, #Antivert/214) •Chewable Tablets: 25 mg (peach, scored, #Antivert/212)" |
|
|
Term
|
Definition
| Tablets: 5 mg (white) and 10 mg (yellow) |
|
|
Term
|
Definition
| "•Tablets: 15 mg (1/4 grain,#TC), 30 mg (1/2 grain, #TD), 60 mg (1 grain, #TE), 90 mg (1.5 grain, #TJ), 120 mg (2 grain, #TF), 180 mg (3 grain, #TG), 240 mg (4 grain, #TH), 300 mg (5 grain, #TI)" |
|
|
Term
|
Definition
| •Arthritec 50 Tablets: Each white tablet contains 50 mg diclofenac sodium and 200 mcg misoprostol •Arthritec 75 Tablets: Each white tablet contains 75 mg diclofenac sodium and 200 mcg misoprostol |
|
|
Term
|
Definition
| "•Tablets, extended release (red-brown, #ASACOL NE): 400 mg" |
|
|
Term
|
Definition
| •Nasal Spray: 0.1% azelastine. Each spray delivers 137 mcg of azelastine HCl. Each package contains two bottles containing 100 sprays each. |
|
|
Term
|
Definition
| "•Tablets: 4 mg (off-white, #ACF/004) 8 mg (light pink, #ACG/008) 16 mg (pink, #ACH/016) 32 mg (pink, #ACL/032)" |
|
|
Term
|
Definition
| "•Tablets: 10 mg (orange), 25 mg (blue), 50 mg (yellow), 100 mg (pink) •Syrup: 10 mg/5 ml (Alcohol 0.5%)" |
|
|
Term
|
Definition
| "•Tablets (white): 0.5 mg(#Wyeth 81), 1.0 mg(#Wyeth 64), and 2.0 mg(#Wyeth 65) •Injection: 2 mg/ml and 4 mg/ml" |
|
|
Term
|
Definition
| •Oral Inhalation: Each actuation of the aerosol delivers 18 mcg of ipratropium. Net weight is 14 grams per canister which delivers 200 inhalations. •Oral Inhalation solution*: 0.02% in 2.5 ml vials. •Nasal Spray: 0.03% (21 mcg per actuation) and 0.06% (42 mcg per actuation) |
|
|
Term
|
Definition
| •Augmentin '250' Tablets: 250 mg amoxicillin and 125 mg clavulanic acid •Augmentin '500' Tablets: 500 mg amoxicillin and 125 mg clavulanic acid •Augmentin '875' Tablets (scored): 875 mg amoxicillin and 125 mg clavulanic acid •Augmentin '200' Chewables: 200 mg amoxicillin and 28.5 mg clavulanic acid •Augmentin '400' Chewables: 400 mg amoxicillin and 57 mg clavulanic acid Oral Suspension (per 5 ml following reconstitution): •Augmentin '125' (banana): 125 mg amoxicillin and 31.25 mg clavulanic acid •Augmentin '200' (orange-raspberry): 200 mg amoxicillin and 28.5 mg clavulanic acid •Augmentin '250' (orange): 250 mg amoxicillin and 62.5 mg clavulanic acid •Augmentin '400' (orange-raspberry): 400 mg amoxicillin and 57 mg clavulanic acid •Augmentin ES-600 (orange-raspberry): 600 mg amoxicillin and 42.9 mg clavulanic acid |
|
|
Term
|
Definition
| •Avalide 150/12.5 tablets: Each peach tablet (#2775) contains irbesartan 150 mg and hydrochlorothiazide 12.5 mg. •Avalide 300/12.5 tablets: Each peach tablet (#2776) contains irbesartan 300 mg and hydrochlorothiazide 12.5 mg. |
|
|
Term
|
Definition
| "•Tablets: 2 mg (pink, SB/2), 4 mg (orange, #SB/4), and 8 mg (red-brown, #SB/8)" |
|
|
Term
|
Definition
| "•Tablets: 75 mg (white, #2771) 150 mg (white, #2772) 300 mg (white, #2773)" |
|
|
Term
|
Definition
| "•Tablets: 400 mg (red, #BAYER M400) •Injection (premix): 400 mg with 0.8% sodium chloride in 250 ml flexible bags." |
|
|
Term
|
Definition
| "•Oral Inhalation: Each canister contains a microcrystalline suspension of 60 mg of triamcinolone acetonide. Each actuation releases 200 mcg, of which approximately 100 mcg is delivered from the inhaler. There are 240 actuations per canister. Azmacort has a built-in spacer device delivery system." |
|
|
Term
|
Definition
| "•Tablets (red-brown): 500 mg •En-tabs®, delayed release tablets (gold,#102): 500 mg" |
|
|
Term
|
Definition
| •Tablets: Trimethoprim / Sulfamethoxazole Bactrim™: 80 mg 400 mg Bactrim™ DS: 160 mg 800 mg •Suspension: Regular (fruit-licorice flavor) 40 mg/5 ml 200 mg/5 ml Pediatric (cherry flavor) 40 mg/5 ml 200 mg/5 ml •Infusion: 80 mg/5 ml 400 mg/5 ml |
|
|
Term
|
Definition
| •Ointment: 2% (20 mg per gram) in a polyethylene glycol base •Nasal Ointment: 2% mupirocin calcium in 1 gram single use tubes. •Cream: 2% mupirocin as mupirocin calcium |
|
|
Term
|
Definition
| "•Tablets: 500 mg (yellow, #MSD 501)" |
|
|
Term
|
Definition
| •Capsules: 10 mg (blue) •Tablets: 20 mg (blue) •Syrup: 10 mg/5 ml •Injection: 10 mg per milliliter |
|
|
Term
|
Definition
| "•Tablets: 250 mg (#KT), 500 mg (#KL) •Tablets, extended-release: 500 mg (yellow, #KJ) •Suspension: 125 mg/5 ml (vanilla), 187 mg/5 ml (fruit) and 250 mg/5 ml (fruit) after reconstitution" |
|
|
Term
|
Definition
| "•Tablets: 0.5 mg (light green), 1 mg (yellow), and 2 mg (peach) •Injection: 0.25 mg/ml in ampules and vials" |
|
|
Term
|
Definition
| "•Tablets: 5 mg (white), 10 mg (white), 15 mg (tri-scored, white, #MJ 822/5 5 5), and 30 mg (tri-scored, peach, #MJ 824/ 10 10 10)" |
|
|
Term
|
Definition
| "•Tablets (white): 12.5 mg (#Squibb/450), 25 mg (#Squibb 452), 50 mg (#Squibb 482), 100 mg (#Squibb 485)" |
|
|
Term
|
Definition
| "•Tablet: 1 gram (pink, #1712) •Suspension: 1 gram / 10 ml (cherry flavor)" |
|
|
Term
| "Cardizem, Cardizem SR & Cardizem CD" |
|
Definition
| "•Tablets (Cardizem): 30 mg(Light green, #Marion/1771), 60 mg(Light yellow, #Marion/1772), 90 mg(Light green, #Cardizem/90mg), 120 mg(Light yellow, #Cardizem/120mg) •Capsules, sustained release twice-a-day (Cardizem SR): 60 mg(dark brown and yellow) 90 mg(dark brown and tan), 120 mg(dark brown and light brown) •Capsules, sustained release once-a-day (Cardizem CD): 180 mg(light turquoise and blue, #1796), 240 mg(blue, #1797), 300 mg(light gray and blue, #1798) •Injection: 5 mg/ml in 25 mg and 50 mg vials and Lyo-Ject™ 25 mg syringe." |
|
|
Term
|
Definition
| "•Tablets: 1 mg (white), 2 mg (yellow), 4 mg (orange), and 8 mg (green)" |
|
|
Term
|
Definition
| "•Tablets: 0.1 mg (Tan, #BI 6), 0.2 mg (Orange, #BI 7), and 0.3 mg (Peach, #BI 11) •Transdermal Extended Release Patches: Catapres-TTS-1: 0.1 mg/24hr (2.5 mg/system) Catapres-TTS-2: 0.2 mg/24hr (5.0 mg/system) Catapres-TTS-3: 0.3 mg/24hr (7.5 mg/system)" |
|
|
Term
|
Definition
| "•Capsules (Pulvules®): 250 mg (white/blue, #Lilly 3061) and 500 mg (blue/gray, #Lilly 3062) •Tablets (Ceclor CD): 500 mg (blue) •Powder for Oral Suspension (strawberry flavor): 125 mg, 187 mg, 250 mg, and 375 mg per 5 ml following reconstitution" |
|
|
Term
|
Definition
| "•Tablets: 125 mg (white, Glaxo/#395), 250 mg (light blue, Glaxo/#387) and 500 mg (dark blue, Glaxo/#394) •Suspension: 125 mg/ 5 ml and 250 mg/5 ml when reconstituted. (Tutti-frutti flavor)" |
|
|
Term
|
Definition
| "•Tablets: 250 mg (orange, #BMS 7720), 500 mg (white, #BMS 7721)* *The appearance of Cefzil tablets will be changing to an engraved style as opposed to the current printed style. The size and the color of the tablets remain the same. •Powder for suspension: 125 mg/ 5 ml and 250 mg/ 5 ml (as anhydrous, bubble gum flavor)" |
|
|
Term
|
Definition
| "•Capsules: 100 mg (white/blue, #7767/100) and 200 mg (white/gold, #7767/200)" |
|
|
Term
|
Definition
| "•Tablets: 10 mg (peach, #10 MG/FP) 20 mg (pink, scored, #20 MG/FP) 40 mg (white, scored #40 MG/FP)" |
|
|
Term
|
Definition
| •Ophthalmic Solution: Each mL of Ciloxin contains ciprofloxacin HCl 3.5 mg equivilant to 3 mg base and benzalkonium chloride 0.006% as a preservative. |
|
|
Term
|
Definition
| "•Tablets: 100 mg, 250 mg, 500 mg, and 750 mg •Oral Suspension: 100 mL after recon stitution containing either 5% or 10% ciprofloxacin. Each package contains powder and diluent. •Injection*: 200 mg in 20 ml vials (1%) and 100 ml in 5% dextrose flexible containers (0.2%), 400 mg in 40 ml vials (1%) and 200 ml in 5% dextrose flexible containers (0.2%)." |
|
|
Term
|
Definition
| "•Capsules: 75 mg (green), 150 mg (green/light blue), and 300 mg (light blue)" |
|
|
Term
|
Definition
| •Transdermal System: Each 6.5 cm2 system contains 2.0 mg of estradiol USP for delivery of 0.025 mg daily. Each 12.5 cm2 system contains 3.9 mg of estradiol USP for delivery of 0.05 mg daily. Each 18.75 cm2 system contains 5.7 mg of estradiol USP for delivery of 0.075 mg daily. Each 25 cm2 system contains 7.8 mg of estradiol USP for delivery of 0.1 mg daily. |
|
|
Term
|
Definition
| "•Tablets: 50 mg (scored, white, #CLOMID 50) *50 mg clomiphene citrate tablets also available from Serono." |
|
|
Term
|
Definition
| •Inhalation Aerosol: Each actuation delivers 18 mcg of ipratropium bromide and 103 mcg of albuterol sulfate from the mouthpiece. Each canister delivers 200 inhalations. |
|
|
Term
|
Definition
| "•Tablets (as maleate): 5 mg (#C66), 10 mg (#C67) •Capsules, long-acting (as maleate): 10 mg (#3344), 15 mg (#3346) •Syrup (as edisylate): 5 mg/5ml •Suppositories: 2.5 mg, 5 mg and 25 mg •Injection (as edisylate): 5 mg/ml" |
|
|
Term
|
Definition
| "•Tablets, extended-release: 18 mg (yellow), 27 mg (gray), 36 mg (white), and 54 mg (brownish red)" |
|
|
Term
|
Definition
| "•Tablets: 3.125 mg (white, #39 SB), 6.25 mg (white, #4140 SB), 12.5 mg (white, #4141 SB), 25 mg (white, #4142 SB)" |
|
|
Term
|
Definition
| "•Solution and Suspension (per ml): 1% hydrocortisone, 5 mg neomycin sulfate, and 10,000 units of polymyxin B sulfate" |
|
|
Term
|
Definition
| •Ophthalmic Solution: Each mL of Cosopt contains 20 mg dorzolamide (22.26 mg dorzolamide HCl) and 5 mg timolol (6.83 mg timolol maleate). Benzalkonium chloride is added as a preservative. |
|
|
Term
|
Definition
| "•Tablets: 1 mg (pink), 2 mg (lavender), 2.5 mg (green), 3 mg (brown), 4 mg (blue), 5 mg (peach), 6 mg (teal), 7.5 mg (yellow), 10 mg (white) •Injection: 50 mg per vial (10 mg NaCl) •Powder for Injection, lyophilized: 2 mg" |
|
|
Term
|
Definition
| "•Tablets, delayed/sustained release: 180 mg and 240 mg" |
|
|
Term
|
Definition
| "•Tablets: 25 mg (light green, teardrop-shaped, film-coated; #MRK/951), 50 mg (green, teardrop-shaped, film-coated; #MRK 952/COZAAR), and 100 mg (dark green, teardrop-shaped)" |
|
|
Term
|
Definition
| "•Tablets: 100 mcg (white, #Searle 1451) and 200 mcg (white, #Searle 1461)" |
|
|
Term
|
Definition
| "•Tablets, Darvocet-N 50: 325 mg acetaminophen and 50 mg propoxyphene napsylate •Tablets, Darvocet-N 100: 650 mg acetaminophen and 100 mg propoxyphene napsylate" |
|
|
Term
|
Definition
| "•Tablets: 2.5 mg (pink, #Upjohn 32), 5 mg (white, #Upjohn 45), 10 mg, (white, #Upjohn 193), 20 mg (peach, #Upjohn 165) and 50 mg (white, #Upjohn 388)" |
|
|
Term
|
Definition
| "•Tablets: 5 mg (white, #102), 10 mg (white, #103), 20 mg (white, #104) and 100 mg (white, #105) •Solution for Injection: 10 mg/mL in 2 mL and 5 mL vials" |
|
|
Term
|
Definition
| "•Tablets (white): 50 mg (#D 35) and 100 mg (#D 37) •Syrup: 50 mg/5 ml (banana flavor) •Injection: Carpuject®: 25 mg, 50 mg, 75 mg and 100 mg in 1 ml cartridges Uni-Amp® and Uni-Nest™: 25 mg, 50 mg, 75 mg and 100 mg ampules. Multiple Dose Vials: 50 mg/ml in 30 ml and 100 mg/ml in 20 ml." |
|
|
Term
|
Definition
| "•Tablets, enteric-coated: 125 mg (salmon pink, #NT), 250 mg (peach, #NR), and 500 mg (lavender, #NS) •Capsules, coated-particles: 125 mg (blue-white) •Tablets, extended-release (Depakote ER): 500 mg (gray, #HC)" |
|
|
Term
|
Definition
| •21 and 28 day blister packs: Each white tablet (#Organon/TR5) contains desogestrel 0.15 mg and ethinyl estradiol 30 mcg. The 28 day blister pack also contains 7 green tablets (#Organon/KH2) containing inert ingredients. |
|
|
Term
|
Definition
| "•Tablets: 50 mg (peach, #MJ 775), 100 mg (white, #MJ 776), 150 mg (peach, #MJ 778), and 300 mg (tan, #MJ 796)" |
|
|
Term
|
Definition
| "•Tablets: 1 mg (white, #TO), and 2 mg (white, #DT) •Capsules, extended release (Detrol LA): 2 mg (blue/green) and 4 mg (blue)" |
|
|
Term
|
Definition
| "•Capsules, sustained release: 5 mg (#SKF E12), 10 mg (#SKF E13), and 15 mg (#SKF E14) •Tablets: 5 mg (yellow, #SKF E19)" |
|
|
Term
|
Definition
|
|
Term
|
Definition
| "•Tablets: 50 mg (pink), 100 mg (pink), 150 mg (pink), 200 mg (pink) •Injection: 2 mg/ml" |
|
|
Term
|
Definition
| "•Capsules, sustained release: 120 mg (gold and white) 180 mg (orange and white) 240 mg (brown and white)" |
|
|
Term
|
Definition
| "•Capsules, extended phenytoin sodium (Dilantin Kapseals®): 30 mg (#PD 365) and 100 mg (#PD 362)" |
|
|
Term
|
Definition
| "•Tablets: 80 mg (pink, #DV), 160 mg ( yellow, #DX), and 320 mg (light grey, #DXL)" |
|
|
Term
|
Definition
| "•80/12.5 Tablets: Each tablet contains 80 mg valsartan and 12.5 mg hydrochlorothiazide (light orange, #CG/HGH) •160/12.5 Tablets: Each tablet contains 160 mg valsartan and 12.5 mg hydrochlorothiazide (dark red, #CG/HHH) •160/25 Tablets: Each tablet contains 160 mg valsartan and 25 mg hydrochlorothiazide (brown, #NVR/HXH)" |
|
|
Term
|
Definition
| "•Tablets: 5 mg (blue, #13/75) •Tablets, extended release (Ditropan XL): 5 mg (yellow), 10 mg (peach), and 15 mg (grey) •Syrup: 5 mg / 5 ml" |
|
|
Term
|
Definition
| •Transdermal Systems: 25 mcg/hour in 10 cm2 (contains 2.5 mg fentanyl) 50 mcg/hour in 20 cm2 (contains 5.0 mg fentanyl)* 75 mcg/hour in 30 cm2 (contains 7.5 mg fentanyl)* 100 mcg/hour in 40 cm2 (contains 10.0 mg fentanyl)* *for use only in opioid tolerant patients. |
|
|
Term
|
Definition
| "•Capsules: 500 mg (#MJ 784) •Tablets: 1000 mg (#MJ 785) •Powder for Oral Suspension: 125 mg, 250 mg and 500 mg/5 ml following reconstitution (orange-pineapple flavor)." |
|
|
Term
|
Definition
| •Capsule: 37.5 mg triamterene and 25 mg HCTZ |
|
|
Term
|
Definition
| "•Tablets: 25 mg (scored, peach, shield-shaped; #25 W/701), 37.5 mg (scored, peach, shield-shaped; #37.5 W/781), 50 mg (scored, peach, shield-shaped; #50 W/703), 75 mg (scored, peach, shield-shaped; #75 W/704), and 100 mg (scored, peach, shield-shaped; #100 W/705) •Capsules, extended-release: 37.5 mg (gray/peach), 75 mg (peach), and 150 mg (dark orange)" |
|
|
Term
|
Definition
| "•Tablets: 10 mg (blue), 25 mg (yellow), 50 mg (beige), 75 mg (orange), 100 mg (mauve), 150 mg (blue) •Injection: 10 mg per ml" |
|
|
Term
|
Definition
| •Ointment: 0.1% •Cream: 0.1% •Lotion: 0.1% with isopropyl alcohol and propylene glycol |
|
|
Term
|
Definition
| "•EpiPen Auto-Injector: Each auto-injector delivers a single dose of 0.3 mg epinephrine from epinephrine injection, USP 1:1000 (0.3 ml) in a sterile solution. •EpiPen Jr. Auto-Injector: Each auto-injector delivers a single dose of 0.15 mg epinephrine from epinephrine injection, USP 1:2000 (0.3 ml) in a sterile solution." |
|
|
Term
|
Definition
| "•Erythromycin Filmtabs: 250 mg (pink, #EB) and 500 mg (pink, #EA) •Capsules, delayed release: 250 mg (maroon/pink & white, #ER) •Tablets, enteric-coated (Ery-Tab): 250 mg (white, #EC), 333 mg (white, #EH) and 500 mg (white,#ED) (Listed in terms of erythromycin activity)" |
|
|
Term
|
Definition
| "•Tablets: 0.5 mg (scored, white, #MJ 421), 1 mg (scored, lavender, #MJ 755) and 2 mg (scored, turquoise, #MJ 756) •Vaginal Cream: 0.1 mg estradiol per gram" |
|
|
Term
|
Definition
| "•Estratest HS tablets: Each light green tablet (#Solvay 1023) contains 0.625 mg esterified estrogens, USP, and 1.25 mg methyltestosterone, USP. •Estratest tablets: Each dark green tablet (#Solvay 1026) contains 1.25 mg esterified estrogens, USP, and 2.5 mg methyltestosterone, USP." |
|
|
Term
|
Definition
| •Tablets: Each of the five white triangular tablets contain 1 mg norethindrone acetate and 20 mcg ethinyl estradiol Each of the seven white square tablets contain 1 mg norethindrone acetate and 30 mcg ethinyl estradiol Each of the nine white round tablets contain 1 mg norethindrone acetate and 35 mcg ethinyl estradiol Each of the seven brown tablets contain 75 mg ferrous fumarate |
|
|
Term
|
Definition
| "•Tablets: 60 mg (white, #LILLY/4165)" |
|
|
Term
|
Definition
| "•Tablets: 125 mg (white, #FAMVIR/125), 250 mg (white, #FAMVIR/250), 500 mg (white, #FAMVIR/500)" |
|
|
Term
|
Definition
| "•Tablets: Each tablet (white, #144) contains 1 mg norethindrone acetate and 5 mcg ethinyl estradiol. Available in bottles of 90 tablets and in blister packs containing 28 tablets each." |
|
|
Term
|
Definition
| "•Tablets: 50 mg butalbital, 325 mg acetaminophen, and 40 mg caffeine" |
|
|
Term
|
Definition
| "•Tablets: 50 mg butalbital, 325 mg aspirin, and 40 mg caffeine •Capsules: 50 mg butalbital, 325 mg aspirin, and 40 mg caffeine" |
|
|
Term
|
Definition
| "•Tablets*: 250 mg and 500 mg (blue) •Capsules: 375 mg (green/white) •Extended Release Tablets (Flagyl ER): 750 mg (blue) •Injection, Flagyl IV™ RTU: 500 mg/100 ml (14mEq. sodium per container) •Powder for injection, Flagyl IV™: 500 mg (as HCl)/vial" |
|
|
Term
|
Definition
| "•Tablets: 10 mg (gold, #MSD 931)" |
|
|
Term
|
Definition
| "•Capsules: 0.4 mg (olive green/opaque, #BI 58)" |
|
|
Term
|
Definition
| "•Spray (60 actuations per 9 g amber glass bottle, 120 actuations per 16 g amber glass bottle): 50 mcg of fluticasone propionate is contained in each actuation of 100 mg of suspension" |
|
|
Term
|
Definition
| "•Inhalation Aerosol: Each canister contains a microcrystalline suspension of fluticasone propionate. Each actuation releases either 44 mcg (Flovent 44), 110 mcg (Flovent 110), or 220 mcg (Flovent 220) from the actuator. Flovent 44 contains 60 actuations and Flovent 110 and Flovent 220 contain 120 actuations. •Rotodisk® Powder: Each blister contains 50 mcg, 100 mcg, or 250 mcg of fluticasone propionate. Administered via a Rotodisk inhalation device." |
|
|
Term
|
Definition
| •Tablets (OTC): 0.4 mg •Tablets (Rx): 0.8 mg and 1 mg •Injection (Rx): 5 mg/mL |
|
|
Term
|
Definition
| "•Tablets: 5 mg (white, #MRK 925), 10 mg (white, #MRK 936), 35 mg (white, #77) and 70 mg (white, #31)" |
|
|
Term
| Glucophage & Glucophage XR |
|
Definition
| "•Tablets: 500 mg (white, #BMS 6060/500) 850 mg (white, #BMS 6070/850) 1000 mg (white, #BMS 6071/1000) •Tablets, extended-release (XR): 500 mg (white, #BMS 6063/500)" |
|
|
Term
|
Definition
| "•Tablets: 5 mg (#Pfizer 411) and 10 mg (#Pfizer 412) •Tablets, sustained-release (XL): 2.5 mg, 5 mg and 10 mg" |
|
|
Term
|
Definition
| "•Glucovance 1.25/250 Tablets: Each tablet (pale yellow, #BMS/6072) contains glyburide 1.25 mg and metformin HCl 250 mg. •Glucovance 2.5/500 Tablets: Each tablet (pale orange, #BMS/6073) contains glyburide 2.5 mg and metformin HCl 500 mg. •Glucovance 5/500 Tablets: Each tablet (yellow, #BMS/6074) contains glyburide 5 mg and metformin HCl 500 mg." |
|
|
Term
|
Definition
| "•Tablets: 1.5 mg (white), 3 mg (blue), and 6 mg (yellow)" |
|
|
Term
|
Definition
| •Humalog: 100 units of insulin lispro per mL •Humalog Mix75/25: 25% insulin lispro solution and 75% insulin lispro protamine suspension •Humalog Mix50/50: 50% insulin lispro solution and 50% insulin lispro protamine suspension |
|
|
Term
|
Definition
| •Lente (L):70% extended-crystalline/30% amorphous insulin •NPH (N): isophane insulin suspension •Regular (R): Humulin is also available in a buffered formula (BR) •Ultralente (U): extended insulin zinc suspension •70/30: 70% isophane/30% insulin •50/50: 50% isophane/50% insulin Humulin insulins are available in 100 units/mL. Humulin R is also available in a concentrated U-500 formulation. |
|
|
Term
|
Definition
| "•Capsules: 1 mg (white, #DF), 2 mg (orange, #DH), 5 mg (tan, #DJ), 10 mg (green, #DI)" |
|
|
Term
|
Definition
| "•Tablets: 50-12.5 contains 50 mg of losartan potassium and 12.5 mg hydrochlorothiazide (yellow, teardrop-shaped, film-coated; #MRK 717/HYZAAR) 100-25 contains 100 mg of losartan potassium and 25 mg hydrochlorothiazide (yellow, teardrop-shaped, film-coated; #MRK 747/HYZAAR) " |
|
|
Term
|
Definition
| "•Tablets, extended release: 30 mg (rose), 60 mg (yellow), and 120 mg (white)" |
|
|
Term
|
Definition
| "•Injection: 6 mg (12 mg/ml) containing sumatriptan (base) as the succinate salt in unit-of-use syringes (0.5 ml in 1 ml) or 6 mg single-dose vials (0.5 ml in 2 ml) •Tablets: 25 mg (white, #I/25), 50 mg (white, #Imitrex/50), and 100 mg (white, #Imitrex/100) . All doses listed are sumatriptan (base) as the succinate •Nasal Spray: 5 mg and 20 mg in 100 mcl unit-dose spray device" |
|
|
Term
|
Definition
| •Tablets (yellow): 50 mg •Powder for Injection: 5 mg/ml in 20 ml vials. Should be dissolved with 10 ml Sterile Water for Injection. Stable for 24 hours after mixing. |
|
|
Term
|
Definition
| "•Tablets: 10 mg, 20 mg, 40 mg, 60 mg, 80 mg •Capsules, sustained release (SR), Inderal LA: 60, 80, 120 and 160 mg •Injection: 1 mg per ml" |
|
|
Term
|
Definition
| "•Capsules (Indocin): 25 mg (MSD 25) and 50 mg (MSD 50) •Capsules, sustained release (Indocin SR by Forte Pharma): 75 mg (693) •Suppository: 50 mg •Suspension: 25 mg/5 ml, pineapple-coconut-mint flavor •Powder for injection (Indocin I.V.): 1 mg per vial" |
|
|
Term
|
Definition
| •Capsules: 15 mg (yellow/gray) and 30 mg (yellow) |
|
|
Term
|
Definition
| "•Scored Tablets (Isoptin): 40 mg (blue), 80 mg (yellow) and 120 mg (white) •Scored Tablets, sustained-release (Isoptin-SR): 120 mg (light violet), 180 mg (light pink) and 240 mg (light green) •Injection: 2.5 mg per ml" |
|
|
Term
|
Definition
| "•Keflex capsules (Pulvules®): 250 mg (#Dista H69) and 500 mg (#Dista H71) •Keflex powder for oral suspension: 100 mg/ml, 125 mg and 250 mg/5 ml (following reconstitution)" |
|
|
Term
|
Definition
| "•Ointment: 0.025%, 0.1%, and 0.5% •Cream: 0.025%, 0.1%, and 0.5% (0.1% is also available in a hydrophilic base) •Lotion: 0.025% and 0.1% •Aerosol: 0.1% per spray •Injection: 10 mg/ml and 40 mg/ml •Kenalog in Orabase: 0.1% in paste form" |
|
|
Term
|
Definition
| "•Tablets: 0.5 mg (Orange, #Klonopin), 1 mg (Blue, #Klonopin 1), and 2 mg (White, #Klonopin 2)" |
|
|
Term
|
Definition
| "•Tablets, chewable: 5 mg (white, #GX CL2) and 25 mg (white, #GX CL5) •Tablets, oral: 25 mg (white, scored), 100 mg (peach, scored), 150 mg (cream, scored), and 200 mg (blue, scored)" |
|
|
Term
|
Definition
| •Tablets: 250 mg (white) •Cream (OTC): 1% •Solution (OTC): 1% |
|
|
Term
|
Definition
| "•Tablets: 0.125 mg (yellow, #Y3B), 0.25 mg (white, #X3A) •Capsules (Lanoxicaps®): 0.05 mg (red, #A2C) , 0.1 mg (yellow, #B2C), and 0.2 mg (green, #C2C) •Elixir Pediatric: 0.05 mg per 1 ml (10% alcohol) •Injection: 0.25 mg per 1 ml (2 ml ampule) •Injection Pediatric: 0.1 mg per 1 ml (1 ml ampule)" |
|
|
Term
|
Definition
| "•Tablets: 20 mg, 40 mg, and 80 mg •Oral Solution: 10 mg/ml (orange flavor) •Injection: 10 mg/ml" |
|
|
Term
|
Definition
| "•Capsules: 20 mg (brown/light brown) 40 mg (brown/gold) •Tablets, extended-release (Lescol XL): 80 mg (yellow) in an extended-release gel matrix delivery system." |
|
|
Term
|
Definition
| "•Tablets: 250 mg (pink), 500 mg (peach), and 750 mg (white)" |
|
|
Term
|
Definition
| "•Tablets: 25 mcg (orange), 50 mcg (white), 75 mcg (purple), 88 mcg (olive), 100 mcg (yellow), 112 mcg (rose), 125 mcg (brown), 137 mcg (dark blue), 150 mcg (blue), 175 mcg (turquoise), 200 mcg (pink), 300 mcg (green). •Dosage equivalence: 0.1 mg L-thyroxine equals approximately 65 mg thyroid, dessicated." |
|
|
Term
|
Definition
| "•Tablets: 0.125 mg (white, #KU/531) •Tablets, sublingual: 0.125mg (blue-green, #532) •Capsules, (Timecaps): 0.375 mg (brown/clear, #Kremers Urban/537) •Tablets, extended-release (Levbid): 0.375 mg (yellow) •Elixir: 0.125 mg/5ml (orange flavored) •Drops: 0.125 mg/ml (orange flavored) •Injection: 0.5 mg/ml (contains sodium metabisulfite) *Also available in dosage forms containing phenobarbital" |
|
|
Term
|
Definition
| "•Tablets: 10 mg (white, #PD 155), 20 mg (white, #PD 156), 40mg (white, #PD 157), and 80 mg (white, #PD 158)" |
|
|
Term
|
Definition
| •Lithonate Capsules (peach): 300 mg •Lithotabs Tablets (white): 300 mg |
|
|
Term
|
Definition
| "•Capsules: 200 mg, 300 mg •Tablets: 400 mg, 500 mg •Tablets, extended-release (Lodine-XL): 400 mg, 500 mg, 600 mg" |
|
|
Term
|
Definition
| •Loestrin FE 1/20: Each of the 21 white tablets contain 1 mg norethindrone and 20 mcg ethinyl estradiol and each of the 7 brown tablets contain 75 mg ferrous fumarate. •Loestrin FE 1.5/30: Each of the 21 green tablets contain 1.5 mg norethindrone and 30 mcg ethinyl estradiol and each of the 7 brown tablets contain 75 mg ferrous fumarate. |
|
|
Term
|
Definition
| •Tablets: 2.5 mg diphenoxylate HCl and 0.025 mg atropine sulfate •Liquid (per 5 ml): 2.5 mg diphenoxylate HCl and 0.025 mg atropine sulfate |
|
|
Term
|
Definition
|
|
Term
|
Definition
| "•Tablets: 50 mg (red, #Geigy /51 51) and 100 mg (blue, #Geigy/ 71 71) •Injection: 5 mg/5 ml" |
|
|
Term
|
Definition
| •Lortab-2.5 Tablets: Each tablet contains 500 mg acetaminophen and 2.5 mg hydrocodone bitartrate •Lortab-5 Tablets: Each tablet contains 500 mg acetaminophen and 5.0 mg hydrocodone bitartrate •Lortab-7 Tablets: Each tablet contains 500 mg acetaminophen and 7.5 mg hydrocodone bitartrate •Lortab-10/500 Tablets: Each tablet contains 500 mg acetaminophen and 10 mg hydrocodone bitartrate •Lortab Elixir: Each 5 mL contains 167 acetaminophen and 2.5 hydrocodone bitartrate (tropical punch flavor) |
|
|
Term
|
Definition
| "•Tablets: 5 mg (light yellow), 10 mg (dark yellow), 20 mg (tan), and 40 mg (dark rose)" |
|
|
Term
|
Definition
| •Lotensin HCT 5/6.25 Tablets: Each white tablet contains benazepril 5 mg and hydrochlorothiazide (HCTZ) 6.25 mg •Lotensin HCT 10/12.5 Tablets: Each light pink tablet contains benazepril 10 mg and HCTZ 12.5 mg •Lotensin HCT 20/12.5 Tablets: Each gray-violet tablet contains benazepril 20 mg and HCTZ 12.5 mg •Lotensin HCT 20/25 Tablets: Each red tablet contains benazepril 20 mg and HCTZ 25 mg |
|
|
Term
|
Definition
| "•Capsules, 2.5/10: 2.5 mg amlodipine and 10 mg benazepril (white with 2 gold bands) •Capsules, 5/10: 5 mg amlodipine and 10 mg benazepril (light brown with 2 white bands) •Capsules, 5/20: 5 mg amlodipine and 20 mg benazepril (pink with 2 white bands)" |
|
|
Term
|
Definition
| •Cream: 1.0% clotrimazole and 0.05% betamethasone •Lotion: 1.0% clotrimazole and 0.05% betamethasone |
|
|
Term
|
Definition
| "•Macrodantin Capsules: 25 mg, 50 mg, and 100 mg nitrofurantoin macrocrystals. •Macrobid Capsules: 100 mg nitrofurantoin in the form of 25 mg of nitrofurantoin macrocrystals and 75 mg nitrofurantoin monohydrate. Nitrofurantoin is available as a suspension under the trade name Furadantin in a concentration of 25 mg/5 mL" |
|
|
Term
|
Definition
| "•Tablets: 1 mg (salmon, #KNOLL 1), 2 mg (yellow, #KNOLL 2), and 4 mg (rose, #KNOLL 4)" |
|
|
Term
|
Definition
| •Inhaler: Each actuation delivers equivalent of 0.2 mg of pirbuterol (300 inhalations) •Autoinhaler: Each breath-activated actuation delivers equivalent of 0.2 mg of pirbuterol (400 inhalations) |
|
|
Term
|
Definition
| "•Maxzide-25 Tablets (green, #M9): 37.5 mg triamterene and 25 mg HCTZ •Maxzide Tablets (yellow, #M8): 75 mg triamterene and 50 mg HCTZ" |
|
|
Term
|
Definition
| "•Tablets: 2 mg (pink, #Upjohn 49), 4 mg (white, #Upjohn 56), 8 mg (orange, #Upjohn 22), 16 mg (white, #Upjohn 73), 24 mg (yellow, #Upjohn 155), and 32 mg (orange, #Upjohn 176) •Topical*: 0.25% and 1.0% (as methylprednisolone acetate) •Injection (Depo-Medrol®)*: 20 mg/ml, 40 mg/ml and 80 mg/ml (as methylprednisolone acetate suspension)" |
|
|
Term
|
Definition
| "•Tablets: 20 mg (light blue) 40 mg (light blue) •Oral Suspension: 40 mg/mL, lemon-lime flavor" |
|
|
Term
|
Definition
| "•Capsules: 5 mg (blue/yellow), 10 mg (blue/white), 15 mg (yellow/white)" |
|
|
Term
|
Definition
| •Vaginal Gel: Each gram of gel contains 7.5 mg metronidazole (0.75%) and is supplied in a 70 gram tube and packaged with 5 vaginal applicators. |
|
|
Term
|
Definition
| "•Tablets: 10 mg (peach, #MSD 730), 20 mg (light blue, #MSD 731), 40 mg (green, #MSD 732)" |
|
|
Term
|
Definition
| •Nasal Spray: Available in 2 mL glass bottles delivering 200 IU (0.09 mL/spray) per activation. Each box contains two bottles with screw-on pumps. •Injection: 200 IU/mL |
|
|
Term
|
Definition
| "•Tablets: 1.25 mg (white), 2.5 mg (dark pink), 5.0 mg (blue)" |
|
|
Term
|
Definition
| "•Capsules: 65 mg isometheptene mucate, 100 mg dichloralphenazone, and 325 mg acetaminophen" |
|
|
Term
|
Definition
| "•Capsules, pellet-filled (microcrystalline cellulose): 50 mg (tan/green, #Lederle M45) and 100 mg (light green/green, #Lederle M46) •Oral Suspension: 50 mg/5 ml (custard-flavored) •Powder for Injection: 100 mg per vial. Should be diluted to 500-1,000 ml after initial dissolution." |
|
|
Term
|
Definition
| •28 day Blister Packs: Each of the 21 white tablets contain 0.15 mg desogestrel and 0.02 mg ethinyl estradiol. Each of the 2 green tablets contain inert ingredients. Each of the 5 yellow tablets contain 0.01 mg ethinyl estradiol. |
|
|
Term
|
Definition
| "•Tablets: 7.5 mg (yellow, #M) and 15 mg (yellow, #M/15)" |
|
|
Term
|
Definition
| "•Tablets: 10 mg (white), 20 mg (white), and 40 mg (white)" |
|
|
Term
|
Definition
| "•Tablets: 400 mg, 600 mg, and 800 mg" |
|
|
Term
|
Definition
| "•Tablets: 15 mg (blue, round, #PF M15), 30 mg (lavender, round, #PF M30), 60 mg (orange, round, #PF M60), 100 mg (gray, round, #PF 100), 200 mg (green, capsule-shaped, #PF 200) *MS Contin 200 mg tablets are for opioid tolerant patients only." |
|
|
Term
|
Definition
| "•Tablets, Naprosyn: 250 mg (yellow, round-shaped, biconvex), 375 mg (peach, capsule-shaped), and 500 mg (yellow, capsule-shaped) •Delayed-release enteric coated tablets, EC-Naprosyn: 375 mg (white, capsule-shaped), 500 mg (white, capsule-shaped) •Suspension: 125 mg/5 ml, pineapple-orange flavor" |
|
|
Term
|
Definition
| •Nasacort Aerosol: Each actuation delivers approximately 55 mcg triamcinolone acetonide (100 sprays per canister) •Nasacort AQ: Each actuation delivers approximately 55 mcg triamcinolone acetanide (120 sprays per unit) |
|
|
Term
|
Definition
| •Nasal Spray: 50 mcg per spray with approximately 120 sprays per bottle. The pump must be primed with approximately 10 actuations before first use and after nonuse of 1 week. |
|
|
Term
|
Definition
| "•Capsules*: 100 mg (white), 300 mg (yellow), and 400 mg (orange) •Tablets: 600 mg (white), and 800 mg (white)" |
|
|
Term
|
Definition
| "•Capsules, delayed-release: 20 mg (amethyst) and 40 mg (amethyst)" |
|
|
Term
|
Definition
| "•Tablets, extended-release: 500 mg (white, #KOS/500), 750 mg (white, #KOS/750), and 1000 mg (white, #KOS/1000)" |
|
|
Term
|
Definition
| •Transdermal infusion system: Nitro-Dur 0.1 mg/hr (20 mg nitroglycerin per system) Nitro-Dur 0.2 mg/hr (40 mg nitroglycerin per system) Nitro-Dur 0.3 mg/hr (60 mg nitroglycerin per system) Nitro-Dur 0.4 mg/hr (80 mg nitroglycerin per system) Nitro-Dur 0.6 mg/hr (120 mg nitroglycerin per system) Nitro-Dur 0.8 mg/hr (160 mg nitroglycerin per system) |
|
|
Term
|
Definition
| "•Tablets, sublingual: 0.15 mg, 0.3 mg, 0.4 mg, 0.6 mg •Injection, (Nitrostat IV): 0.8 mg/ml, 5 mg/ml, 10mg/ml" |
|
|
Term
|
Definition
| "•Tablets: 200 mg (white, #Janssen/Nizoral) •Cream: 2% in an aqueous vehicle •Shampoo (OTC): 2% in an aqueous suspension" |
|
|
Term
|
Definition
| "•Tablets: 10 mg tamoxifen as the citrate (white, k#600) 20 mg tamoxifen as the citrate (white, #604)" |
|
|
Term
|
Definition
| "•Tablets (white): 2.5 mg, 5 mg, and 10 mg" |
|
|
Term
|
Definition
| •Ophthalmic Solution: Each mL of Ocuflox contains ofloxacin 3 mg and benzalkonium chloride 0.005% as a preservative. |
|
|
Term
|
Definition
| •Capsules: 300 mg (lavender and turquoise) •Powder for Oral Suspension: 125 mg/5 mL following reconstitution. Available in 60 mL and 100 mL bottles. Strawberry flavor. |
|
|
Term
| Ortho Tri-Cyclen & Tri-Cyclen Lo |
|
Definition
| "•Ortho Tri-Cyclen*: Each white tablet, #Ortho/180 (first seven days): norgestimate 0.18 mg, ethinyl estradiol 35 mcg Each light blue tablet, #Ortho/215 (next seven days): norgestimate 0.215 mg, ethinyl estradiol 35 mcg Each blue tablet, #Ortho/250 (last seven days): norgestimate 0.25 mg, ethinyl estradiol 35 mcg *28 day Dialpak includes 7 green inert tablets" |
|
|
Term
|
Definition
| "•Ortho-Cyclen*: Each blue tablet, #Ortho/259: norgestimate 0.25 mg, ethinyl estradiol 35 mcg *28 day Dialpak includes 7 green inert tablets" |
|
|
Term
|
Definition
| "•1/35-21 day and 28* day Dialpak®: Each peach tablet, #Ortho/135: norethindrone 1 mg, ethinyl estradiol 35 mcg •10/11-21 day and 28* day Dialpak: Each white tablet, #Ortho/535 (first ten days): norethindrone 0.5 mg, ethinyl estradiol 35 mcg; Each peach tablet, #Ortho/135 (next eleven days): norethindrone 1 mg, ethinyl estradiol 35 mcg •7/7/7-21 day and 28* day Dialpak: Each white tablet,#Ortho/535 (first seven days): norethindrone 0.5 mg, ethinyl estradiol 35 mcg; Each light peach tablet,#Ortho/75 (second seven days): norethindrone 0.75 mg, ethinyl estradiol 35 mcg; Each peach tablet, #Ortho/135 (third seven days): norethindrone 1 mg, ethinyl estradiol 35 mcg *28 day Dialpak includes 7 green inert tablets" |
|
|
Term
|
Definition
| "•Tablets, controlled-release: 10 mg (white, #OC/10), 20 mg (pink, #OC/20), 40 mg (yellow, #OC/40), 80 mg (green, #OC/80)" |
|
|
Term
|
Definition
| "•Capsules: 10 mg (orange/white), 25 mg (white/orange), 50 mg (white), and 75 mg (orange) •Oral Solution: 10 mg base per 5 ml (4% alcohol)" |
|
|
Term
|
Definition
| •Ophthalmic drops: 0.1% olopatadine HCl (also contains benzalkonium chloride as a preservative) |
|
|
Term
|
Definition
| "•Tablets: 10 mg (yellow), 20 mg (pink, scored), 30 mg (blue), 40 mg (lime green) •Tablets, controlled-release (Paxil CR): 12.5 mg (yellow), 25 mg (pink), and 37.5 mg (blue) •Oral Suspension: 10 mg/5 mL (orange-flavored)" |
|
|
Term
|
Definition
| "•Tablets: 20 mg (beige) and 40 mg (orange) •Orally Disintegrating Tablets: (Pepcid RPD) 20 mg (pale rose, hexagonal) and 40 mg (pale rose, hexagonal) •Powder for Oral Suspension: 40 mg/5 mL after reconstitution (cherry-banana-mint flavor). Stable for 30 days after mixing. •Premixed Injection: 20 mg/50mL •Injection: 10 mg/mL. Stable for 48 hours after mixing with commonly used intravenous solutions." |
|
|
Term
|
Definition
| "•Percocet 2.5/325 Tablets (pink)*: 325 mg acetaminophen and 2.5 mg oxycodone HCl •Percocet 5/325 Tablets (blue, scored)*: 325 mg acetaminophen and 5 mg oxycodone HCl •Percocet 7.5/325 Tablets (pink): 325 mg acetaminophen and 7.5 mg oxycodone HCl •Percocet 10/325 Tablets (yellow): 325 mg acetaminophen and 10 mg oxycodone HCl •Percocet 7.5/500 Tablets (peach)*: 500 mg acetaminophen and 7.5 mg oxycodone HCl •Percocet 10/650 Tablets (yellow)*: 650 mg acetaminophen and 10 mg oxycodone HCl" |
|
|
Term
|
Definition
| "•Tablets: 12.5 mg (orange, #19), 25 mg (white, #27), 50 mg (pink, #227) •Syrup, Phenergan Plain: 6.25 mg per 5 ml •Syrup, Phenergan Fortis: 25 mg per 5 ml •Suppositories: 12.5 mg, 25 mg, and 50 mg •Injection: 25 mg/ml and 50 mg/ml" |
|
|
Term
|
Definition
| •Syrup (per 5 ml): 6.25 mg promethazine HCl and 10 mg codeine phosphate with 7% alcohol |
|
|
Term
|
Definition
| "•Tablets (metric weight system): 15 mg , 30 mg, 60 mg, 100 mg •Tablets (apothecary weight system): 1/4 gr (16.2 mg) , 1/2 gr (32.4 mg), 1 gr (64.8 mg), and 1 1/2 gr (97.2 mg) •Elixir: 20 mg/5 ml (alcohol 14%)" |
|
|
Term
|
Definition
| •Tablets: 200 mg (equivalent to 155 mg of base) |
|
|
Term
|
Definition
| •Tablets: 75 mg (pink/#75) |
|
|
Term
|
Definition
| "•Tablets, extended-release: 2.5 mg (sage-green, round, convex, #450/Plendil) 5 mg (light red-brown, round, convex, #451/Plendil) and 10 mg (red-brown, round, convex, #452/Plendil)" |
|
|
Term
|
Definition
| •Tablets: 50 mg (white) and 100 mg (white) |
|
|
Term
|
Definition
| "•Slow K Tablets (wax matrix, sugar-coated): 8 mEq. (600 mg) •K-Tab Tablets (wax matrix, film-coated): 10 mEq. (750 mg) •K-Dur Tablets, controlled-release micro-crystalloids: 10 mEq (750 mg), 20 mEq (1500 mg) •Micro-K Extencaps: 8 mEq. [600 mg], (#AHR 5720) •Micro-K 10 Extencaps: 10 mEq. [750 mg], (#AHR 5730) •Micro-K LS Powder for Suspension: 20 mEq per packet •Klor-Con Powder: 20 mEq per packet, fruit flavor •Klor-Con/25 Powder: 25 mEq per packet, fruit flavor •Klor-Con/EF Powder: 25 mEq (as bicarbonate and citrate), orange •Klor-Con 8 Tablets: 8 mEq (600 mg) •Klor-Con 10 Tablets: 10 mEq (750 mg)" |
|
|
Term
|
Definition
| "•Tablets: 0.5 mg (white), 1 mg (yellow) and 2 mg (peach)" |
|
|
Term
|
Definition
| •Tablets: 10 mg (pink) 20 mg (yellow) 40 mg (green) 80 mg (yellow) |
|
|
Term
|
Definition
| "•Tablets: 0.3 mg (green), 0.625 mg (maroon), 0.9 mg (white), 1.25 mg (yellow) and 2.5 mg (purple) •Premarin vaginal cream: 0.625 mg conjugated estrogens per 1 gram •Premarin Intravenous: 25 mg conjugated estrogens per Secule® (vial) *Also available in a formulation with methyltestosterone" |
|
|
Term
|
Definition
| "•Prempro 0.625/2.5 Tablets (oval, peach): Each tablet contains 0.625 mg of the conjugated estrogens found in Premarin® and 2.5 mg medroxyprogesterone acetate. •Prempro 0.625/5 Tablets (oval, peach): Each tablet contains 0.625 mg of the conjugated estrogens found in Premarin® and 5 mg medroxyprogesterone acetate. " |
|
|
Term
|
Definition
| "•Capsules, delayed release: 15 mg (pink and blue) and 30 mg (pink and black)" |
|
|
Term
|
Definition
| "•Capsules, sustained release: 10 mg (apricot/amethyst, #606) 20 mg (amethyst, #742) 40 mg (amethyst/tan, #743)" |
|
|
Term
|
Definition
| "•Tablets: 2.5 mg (white, #MSD 15) 5 mg (white, #MSD 19) 10 mg (yellow, #MSD 106) 20 mg (peach, #MSD 207) 40 mg (red, #MSD 237)" |
|
|
Term
|
Definition
| "•Prinzide 10-12.5 Tablets: Each tablet contains lisinopril 10 mg and hydrochlorothiazide 12.5 mg (blue, #MSD 145/PRINZIDE) •Prinzide 20-12.5 Tablets: Each tablet contains lisinopril 20 mg and hydrochlorothiazide 12.5 mg (yellow, #MSD 140/PRINZIDE) •Prinzide 20-25 Tablets: Each tablet contains lisinopril 20 mg and hydrochlorothiazide 25 mg (peach, #MSD 142/PRINZIDE)" |
|
|
Term
|
Definition
| "•Capsules: 10 mg (orange) and 20 mg (orange/brown) •Tablets, sustained release (Procardia XL): 30 mg, 60 mg, and 90 mg" |
|
|
Term
|
Definition
| "•Capsules: 100 mg (peach, #SV) and 200 mg (pale yellow, #SV2) of micronized progesterone. Inactive ingredients include peanut oil." |
|
|
Term
|
Definition
|
|
Term
|
Definition
| "•Tablets (blue, #MSD 72/PROSCAR): 5 mg" |
|
|
Term
|
Definition
| "•Tablets, delayed-release: 40 mg (yellow) •Powder for Injection, freeze-dried: 40 mg/vial" |
|
|
Term
|
Definition
| "•Aerosol inhaler*: 90 mcg albuterol per actuation (approximately 200 actuations per canister)* •Aerosol inhaler, CFC-free (Proventil HFA): 108 mcg albuterol sulfate per spray (200 inhalations)* •Solution for inhalation*: 0.5% (concentrated) and 0.083% (unit dose) *Also available in a hospital pack with less inhalations per canister." |
|
|
Term
|
Definition
| "•Tablets: 2.5 mg (peach), 5 mg (white), and 10 mg (white)" |
|
|
Term
|
Definition
| "•Tablets: 10 mg (green, scored) •Capsules: 10 mg (green, #3104), 20 mg (green/off-white, #3105), 40 mg (green/orange, #3107) •Capsules, delayed-release: 90 mg (opaque green/clear, #LILLY 3004 90 mg) •Liquid: 20 mg /5 ml (mint flavor)" |
|
|
Term
|
Definition
| •Tablets (dark red): 100 mg (#PD 180) and 200 mg (#PD 181) |
|
|
Term
|
Definition
| •Tablets: 5 mg (green) and 10 mg (white) metoclopramide base •Syrup: 5 mg/5 ml metoclopramide base •Injectable: 5 mg/1 ml metoclopramide base |
|
|
Term
|
Definition
| "•Tablets: 500 mg (white, oval, #Relafen/500) and 750 mg (tan, oval, #Relafen/750)" |
|
|
Term
|
Definition
| "•Tablets: 15 mg (yellow, #Organon/TZ3), 30 mg (red-brown, #Organon/TZ5), and 45 mg (white, #Organon/TZ7) •SolTabs® (orally disintegrating tablets): 15 mg (white, #TZ1), 30 mg (white, #TZ2), and 45 mg (white, #TZ4)" |
|
|
Term
|
Definition
| "•Capsules: 7.5 mg (blue/pink), 15 mg (maroon/pink), and 30 mg (maroon/blue)" |
|
|
Term
|
Definition
| "•Cream: 0.025%, 0.05%, 0.1% •Gel: 0.025%, 0.01% •Microsphere Gel: 0.04% and 0.1% •Liquid: 0.05%" |
|
|
Term
|
Definition
| •Nasal Inhaler (Rhinocort): Each actuation delivers approximately 50 mcg budesonide from the valve and delivers 32 mcg to the patient (200 sprays per unit) •Nasal Spray (Rhinocort AQ): Each spray delivers approximately 32 mcg budesonide to the patient. |
|
|
Term
|
Definition
| "•Tablets: 0.25 mg (gold, #R 0.25), 0.5 mg (dark red, #R 0.5), 1 mg (white, #R 1), 2 mg (orange, #R 2), 3 mg (yellow, #R 3), and 4 mg (green, #R 4) •Oral Solution: 1 mg/mL " |
|
|
Term
| "Ritalin, Ritalin SR & Ritalin LA" |
|
Definition
| "•Tablets: 5 mg (yellow, #Ciba/7), 10 mg (pale green, #Ciba/3), 20 mg (pale yellow, #Ciba/34) •Tablets, sustained-release (Ritalin-SR®): 20 mg (white, #Ciba/16) •Capsules, sustained-release (Ritalin LA): 20 mg, 30 mg, 40 mg" |
|
|
Term
|
Definition
| •Tablets (orange): 500 mg and 750 mg •Injection: 100 mg/ml in 10 ml single-dose vials |
|
|
Term
|
Definition
| "•Aerosol inhaler: 25 mcg salmeterol base (as salmeterol xinafoate) per actuation. (Approximately 60 actuations per 6.5 g canister, 13 g/120 actuation refill canisters also available.) •Serevent Diskus: Available in a disposable teal green colored device containing 60 blisters. Each blister contains 50 mcg salmeterol base (as salmeterol xinafoate) in a powder form." |
|
|
Term
|
Definition
| "•Tablets: 25 mg (peach), 100 mg (yellow), 200 mg (white), and 300 mg (white)" |
|
|
Term
|
Definition
| "•Tablets: 50 mg (peach, hexagonal; BMS 50/31), 100 mg (scored, white, hexagonal; #BMS 100/32), 150 mg (scored, peach, hexagonal; #BMS 150/39), 200 mg (light yellow, hexagonal; #BMS 200/33), 250 mg (white, hexagonal; #BMS 250/41)" |
|
|
Term
|
Definition
| "•Sinemet 10/100 (blue, #MSD 647): 10 mg carbidopa and 100 mg levodopa •Sinemet 25/100 (yellow, #MSD 650): 25 mg carbidopa and 100 mg levodopa •Sinemet 25/250 (light blue, #MSD 654): 25 mg carbidopa and 250 mg levodopa •Sinemet 25/100 CR (peach, #MSD 601): 25 mg carbidopa and 100 mg levodopa •Sinemet 50/200 CR (peach, #MSD 521): 50 mg carbidopa and 200 mg levodopa" |
|
|
Term
|
Definition
| "•Capsules (doxepin equivalent): 10 mg (red/pink, #534), 25 mg (blue/pink, #535), 50 mg (pink/peach, #536), 75 mg (peach, #539), 100 mg (blue/peach, #538), 150 mg (blue, #537) •Oral concentrate (doxepin equivalent): 10 mg per ml" |
|
|
Term
|
Definition
| "•Tablets, chewable: 4 mg (pink, #MRK 711/SINGULAIR), and 5 mg (pink, #MRK 275/SINGULAIR), cherry flavor •Tablets: 10 mg (beige, MRK 117/SINGULAIR)" |
|
|
Term
|
Definition
| "•Tablets: 400 mg (pale rose, #8662/C)" |
|
|
Term
|
Definition
| "•Tablets (white, #SOMA/37-WALLACE 2001): 350mg" |
|
|
Term
|
Definition
| •Capsules: 5 mg (green/pale green) and 10 mg (green/light green) |
|
|
Term
|
Definition
| "•Capsule: 100 mg (blue/pink, #JANSSEN/SPORANOX 100) •Oral solution: 10 mg/ mL (cherry/caramel flavor) •Injection: 10mg/mL" |
|
|
Term
|
Definition
| "•Tablets: 250 mg (pink, #Squibb 663) and 500 mg (pink, #Squibb 603) •Oral suspension: 125 mg/5 mL (fruit flavor)" |
|
|
Term
|
Definition
| "•Tablets: 25 mcg (orange), 50 mcg (white), 75 mcg (violet), 88 mcg (olive), 100 mcg (yellow), 112 mcg (rose), 125 mcg (brown), 150 mcg (blue), 175 mcg (lilac), 200 mcg (pink), 300 mcg (green). •Injection: 200 mcg and 500 mcg per vial (following reconstitution). •Dosage equivalence: 0.1 mg L-thyroxine equals approximately 65 mg thyroid, dessicated." |
|
|
Term
|
Definition
| "•Tablets: 200 mg, 300 mg, 400 mg, and 800 mg •Liquid: Cimetidine HCl equivalent to 300 mg cimetidine/5 ml (alcohol 2.8%) •Injection: Cimetidine HCl equivalent to 300 mg cimetidine/2 ml (phenol 10 mg)" |
|
|
Term
|
Definition
| •Tablets (white. #W/T51): Pentazocine HCl equivalent to 50 mg pentazocine base and naloxone HCl equivalent to 0.5 mg naloxone base. *Talwin is available in an injectable dosage form. |
|
|
Term
|
Definition
| "•Tablets, chewable*: 100 mg •Tablets, oral*: 200 mg •Tablets, extended-release (Tegretol-XR)*: 100 mg (yellow), 200 mg (pink), and 400 mg (brown) •Suspension: 100 mg / 5 ml (vanilla flavor)" |
|
|
Term
|
Definition
| "•Tablets: 25 mg (white, #T/107), 50 mg (white, #105), and 100 mg (white, #101) •Injection: 5 mg/10 ml " |
|
|
Term
|
Definition
| "•Tablets: 200 mg (white, #BMS TEQUIN 200) 400 mg (white, #BMS TEQUIN 400) •Solution for injection: 200 mg and 400 mg in single-use vials or pre-mix flexible containers." |
|
|
Term
|
Definition
| •Terazol 7 Cream: 0.4%(20 mg per applicatorful) for 7 day therapy. •Terazol 3 Cream: 0.8%(40 mg per applicatorful) for 3 day therapy. •Terazol 3 Suppository: 80 mg per suppository for 3 day therapy. |
|
|
Term
|
Definition
| •Capsules (Perles): 100 mg (yellow) and 200 mg (yellow) |
|
|
Term
|
Definition
| "•Capsules, extended-release: 120 mg (lavender), 180 mg (white/blue-green), 240 mg (blue-green/lavender), 300 mg (white/lavender), 360 mg (blue-green), 420 mg (white)" |
|
|
Term
|
Definition
| "•Capsules: 100 mg and 250 mg •Suppositories, Pediatric: 100 mg •Suppositories, Adult: 200 mg •Injection: 100 mg/ml" |
|
|
Term
|
Definition
| •Ophthalmic Solution: 0.25% and 0.5% Available in Ocudose patient compliance bottle. •Ophthalmic Gel (Timoptic-XE): 0.25% and 0.5% |
|
|
Term
|
Definition
| •Ophthalmic Suspension: Each mL contains tobramycin 0.3% (3 mg) and dexamethasone 0.1% (1 mg) •Ophthalmic Ointment: Each gram contains tobramycin 0.3% (3 mg) and dexamethasone 0.1% (1 mg) |
|
|
Term
|
Definition
| "•Tablets: 10 mg, 25 mg, and 50 mg (as hydrochloride) •Capsules, long-acting: 75 mg, 100 mg, 125 mg, and 150 mg (as pamoate) •Injection: 25 mg/2 ml (as hydrochloride)" |
|
|
Term
|
Definition
| "•Sprinkle Capsules: 15 mg (white. #TOP/15) and 25 mg (white, #TOP/25) •Tablets: 25 mg (white, #TOP/25), 100 mg (yellow, #TOP/100), and 200 mg (salmon, #TOP/200)" |
|
|
Term
|
Definition
| "•Tablets, extended-release: 25 mg (white,scored,# A B) 50 mg (white,scored,# A mo), 100 mg (white, scored, # A ms), 200 mg (white, scored, # A my)" |
|
|
Term
|
Definition
| "•Tablets: 10 mg (white, round, #Toradol/Syntex) •Injection: 15 mg, 30 mg, and 60 mg in 1 mL Cartrix® or TUBEX® units" |
|
|
Term
|
Definition
| "•Tablet, controlled-release: 400 mg (pink)" |
|
|
Term
|
Definition
| "•Tablets: 54 mg (yellow, #TA) and 160 mg (white, #TC)" |
|
|
Term
|
Definition
| "•Triphasil-21 day: Each brown tablet, (first six days): levonorgestrel 0.05 mg and ethinyl estradiol 30 mcg Each white tablet, (next five days): levonorgestrel 0.075 mg and ethinyl estradiol 40 mcg Each yellow tablet, (last ten days): levonorgestrel 0.125 mg and ethinyl estradiol 30 mcg •Triphasil-28 day: Same as above plus 7 green inert tablets." |
|
|
Term
|
Definition
| •Pennkinetic® Suspension (extended release): 8 mg chlorpheniramine and 10 mg hydrocodone as polistirex per 5 ml |
|
|
Term
|
Definition
| •Tylenol No.2 Tablets: 300 mg acetaminophen and 15 mg codeine phosphate •Tylenol No.3 Tablets: 300 mg acetaminophen and 30 mg codeine phosphate •Tylenol No.4 Tablets: 300 mg acetaminophen and 60 mg codeine phosphate •Elixir: Each 5 ml contains acetaminophen 120 mg and codeine phosphate 12 mg (cherry flavor). Tylenol with Codeine Elixir is a schedule C-V medication. |
|
|
Term
|
Definition
| "•Tablets: 50 mg (white, film-coated, #McNeil/659)" |
|
|
Term
|
Definition
| "•Tablets: 7.5 mg (pink, #707) and 15 mg (salmon, #715)" |
|
|
Term
|
Definition
| "•Tablets: 2 mg (white), 5 mg (yellow), and 10 mg (blue) •Injection: 5 mg/ml" |
|
|
Term
|
Definition
| •Tablets: 500 mg (blue) and 1000 mg (blue) |
|
|
Term
|
Definition
| "•Capsules (Pulvules®): 125 mg (blue/brown, #Lilly 3125) and 250 mg (blue/lavender, #Lilly 3126) •Powder for Oral Solution: 1 g (screw-cap bottle) and 10 g (screw-cap bottle) •Injection (Vials): 500 mg in 10 ml vials and 1 g in 20 ml vials •Injection (ADD-Vantage Vials*): 500 mg in 15 ml vials and 1 g in 15 ml vials •Injection (Pharmacy Bulk Package): 10 g in 100 ml *Powder for injection available from several sources." |
|
|
Term
|
Definition
| "•Tablets: 2.5 mg (yellow, MSD 14), 5 mg (white, MSD 712), 10 mg (salmon, MSD 713), 20 mg (peach, MSD 714) •Injection: 1.25 mg enalaprilat in 1 and 2 ml vials. " |
|
|
Term
|
Definition
| "•Tablets, film-coated: 250 mg (white, #BL V1) and 500 mg (white, #BL V2) •Powder for Oral Solution: 125 mg and 250 mg/5 ml when reconstituted (contains saccharin)." |
|
|
Term
|
Definition
| "•Verelan capsules, sustained-release*: 120 mg (yellow), 180 mg (light gray/yellow), 240 mg (dark blue/yellow), 360 mg (lavender/yellow) •Verelan PM capsules, sustained-release: 100 mg (white/amethyst), 200 mg (amethyst), 300 mg (lavender/amethyst)" |
|
|
Term
|
Definition
| "•Tablets: 25 mg (blue, #PFIZER/VGR25), 50 mg (blue, #PFIZER/VGR50), 100 mg (blue, #PFIZER/VGR100)" |
|
|
Term
| Vibramycin and Vibra-Tabs |
|
Definition
| "•Vibra-Tabs: 100 mg (orange, #Pfizer 099) •Vibramycin Capsules: 50 mg (#Pfizer 094), 100 mg (#Pfizer 095) •Syrup: 50 mg as calcium salt/5 ml (Raspberry/apple-flavored suspension) •Powder for Oral Suspension: 25 mg as monohydrate/5 ml after reconstitution (Raspberry flavor) •Powder for injection: 100 mg and 200 mg per vial " |
|
|
Term
|
Definition
| "•Tablets: Each tablet contains 7.5 mg hydrocodone bitartrate, USP and 200 mg ibuprofen, USP (white, film-coated, #VP)" |
|
|
Term
|
Definition
| "•Tablets: 12.5 mg (cream, #MRK 74/VIOXX), 25 mg (yellow, #MRK 110/VIOXX), and 50 mg (tan, #MRK 114/VIOXX) •Oral Suspension: 12.5 mg/5 mL (strawberry) and 25 mg/5 mL (strawberry)" |
|
|
Term
|
Definition
| "•Tablets, Delayed-Release: 25 mg (yellow), 50 mg (light brown), and 75 mg (pink) •Tablets, Extended-Release (Voltaren-XR): 100 mg (pink) •Ophthalmic Solution: 0.1% (distributed by Ciba Vision)" |
|
|
Term
| Wellbutrin & Wellbutrin SR |
|
Definition
| "•Tablets: 75 mg (yellow-gold) and 100 mg (red) •Tablets, sustained release (Wellbutrin SR): 100 mg (blue) and 150 mg (purple) *Immediate-release tablets are available in generic form." |
|
|
Term
|
Definition
| •Ophthalmic Solution: Each 2.5 mL dispenser bottle contains 0.005% latanoprost |
|
|
Term
|
Definition
| "•Tablets: 0.25 mg (white), 0.5 mg (peach), 1 mg (blue), and 2 mg (white, tri-scored)" |
|
|
Term
|
Definition
| •Capsules: 120 mg (dark-blue) |
|
|
Term
|
Definition
| "•Tablets: 2 mg (white, #592) and 4 mg (white, #594)" |
|
|
Term
|
Definition
| •Tablets: 150 mg and 300 mg •GELdose™ capsules: 150 mg and 300 mg •EFFERdose™ granules and tablets: 150 mg •Syrup: 15 mg/ml (peppermint flavor) •Injection: 25 mg/ml |
|
|
Term
|
Definition
| "•Tablets: 2.5 mg (pink), 5.0 mg (blue), and 10.0 mg (yellow)" |
|
|
Term
|
Definition
| "•Zestoretic 10-12.5 Tablets: Lisinopril 10 mg and hydrochlorothiazide 12.5 mg (peach, #141/Zestoretic) •Zestoretic 20-12.5 Tablets: Lisinopril 20 mg and hydrochlorothiazide 12.5 mg (white, #142/Zestoretic) •Zestoretic 20-25 Tablets: Lisinopril 20 mg and hydrochlorothiazide 25 mg (peach, #145/Zestoretic)" |
|
|
Term
|
Definition
| "•Tablets: 2.5 mg (white,#135) 5 mg (pink, #130) 10 mg (pink, #131) 20 mg (red, #132) 30 mg (pink, #133) 40 mg (yellow, #134)" |
|
|
Term
|
Definition
| "Ziac 2.5 mg/6.25 mg Tablets: Bisoprolol fumarate 2.5 mg and hydrochlorothiazide 6.25 mg (yellow, #LL/B12) Ziac 5 mg/6.25 mg Tablets: Bisoprolol fumarate 5 mg and hydrochlorothiazide 6.25 mg (pink, #LL/B13) Ziac 10 mg/6.25 mg Tablets: Bisoprolol fumarate 10 mg and hydrochlorothiazide 6.25 mg (white, #LL/B14)" |
|
|
Term
|
Definition
| "•Tablets: 250 mg (red, #PFIZER/306) and 500 mg (pink, #PFIZER/ZTM500) •Packets: Each packet contains 1 gm following reconstitution •Suspension: 300 mg (100 mg/5 mL), 600 mg, 900 mg and 1200 mg (each containing 200 mg/5 mL) azithromycin per bottle following reconstitution. •Powder for Injection: Each vial contains 500 mg of azithromycin in a lyophilized form." |
|
|
Term
|
Definition
| "•Tablets: 5 mg (buff, #MSD 726), 10 mg (peach, #MSD 735), 20 mg (tan, #MSD 740), 40 mg (red, #MSD 749), and 80 mg (red, #543/80)" |
|
|
Term
|
Definition
| "•Tablets: 4 mg (white), 8 mg (yellow) •Tablets, orally-disintegrating (Zofran ODT): 4 mg (white) and 8 mg (white) •Oral solution: 4 mg/5 mL (strawberry) •Injectable: 2 mg/ml in vials" |
|
|
Term
|
Definition
| "•Tablets: 25 mg (light green), 50 mg (light blue), 100 mg (light yellow) •Oral concentrate: 20 mg/mL (12% alcohol)" |
|
|
Term
|
Definition
| •Capsules: 200 mg •Tablets: 400 mg and 800 mg •Ointment: 5.0% •Suspension: 200 mg/5 ml (banana flavor) •Powder for Injection: 50 mg/ml following reconstitution |
|
|
Term
|
Definition
| "•Tablets, sustained release: 150 mg (purple, #Zyban 150)" |
|
|
Term
|
Definition
| •Tablets: 100 mg (white) and 300 mg (orange) |
|
|
Term
|
Definition
| "•Tablets: 2.5 mg (white, #LILLY/4112), 5 mg (white, #LILLY/4115), 7.5 mg (white, #LILLY/4116), 10 mg (white, #LILLY/4117), 15 mg (blue, #4415), 20 mg (pink, #LILLY 4420) •Tablets, orally disintegrating (ZYDIS): 5 mg (yellow, round), and 10 mg (yellow, round)" |
|
|
Term
|
Definition
| •Tablets: 5 mg (white) 10 mg (white) •Syrup: 5 mg per 5 mL (banana-grape flavor) |
|
|
